Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A large epidemiological study of erythema multiforme in France, with emphasis on treatment choices.
Kechichian E, Ingen-Housz-Oro S, Sbidian E, Hemery F, Bernier C, Fite C, Delaunay J, Staumont-Sallé D, Toukal F, Dupin N, Abasq C, Samimi M, Picard C, Hebert V, Prost C, Monfort JB, Milpied B, Wolkenstein P, Chosidow O. Kechichian E, et al. Among authors: abasq c. Br J Dermatol. 2018 Oct;179(4):1009-1011. doi: 10.1111/bjd.16928. Epub 2018 Aug 16. Br J Dermatol. 2018. PMID: 29957881 No abstract available.
Systemic treatments in childhood psoriasis: a French multicentre study on 154 children.
Charbit L, Mahé E, Phan A, Chiaverini C, Boralevi F, Bourrat E, Lasek A, Maruani A, Aubin F, Droitcourt C, Barbarot S, Mallet S, Mazereeuw-Hautier J, Begon E, Abasq C, Plantin P, Souillet AL, Hadj-Rabia S, Bursztejn AC; Groupe de Recherche de la Société Française de Dermatologie Pédiatrique. Charbit L, et al. Among authors: abasq c. Br J Dermatol. 2016 May;174(5):1118-21. doi: 10.1111/bjd.14326. Epub 2016 Feb 11. Br J Dermatol. 2016. PMID: 26617180 No abstract available.
Calculation of cut-off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus.
Boulard C, Duvert Lehembre S, Picard-Dahan C, Kern JS, Zambruno G, Feliciani C, Marinovic B, Vabres P, Borradori L, Prost-Squarcioni C, Labeille B, Richard MA, Ingen-Housz-Oro S, Houivet E, Werth VP, Murrell DF, Hertl M, Benichou J, Joly P; International Pemphigus Study Group. Boulard C, et al. Br J Dermatol. 2016 Jul;175(1):142-9. doi: 10.1111/bjd.14405. Epub 2016 Apr 3. Br J Dermatol. 2016. PMID: 26800395 Free article.
[Oral care recommendations for patients with oral autoimmune bullous diseases].
Sobocinski V, Dridi SM, Bisson C, Jeanne S, Gaultier F, Prost-Squarcioni C, Bernard P, Pascal F, Lefevre B, Weber P, Abasq C, Agbo-Godeau S, Joly P, Ingen-Housz-Oro S, Duvert-Lehembre S. Sobocinski V, et al. Among authors: abasq c. Ann Dermatol Venereol. 2017 Mar;144(3):182-190. doi: 10.1016/j.annder.2016.09.680. Epub 2016 Dec 20. Ann Dermatol Venereol. 2017. PMID: 28011091 French.
Large International Validation of ABSIS and PDAI Pemphigus Severity Scores.
Hébert V, Boulard C, Houivet E, Duvert Lehembre S, Borradori L, Della Torre R, Feliciani C, Fania L, Zambruno G, Camaioni DB, Didona B, Marinovic B, Schmidt E, Schumacher N, Hünefeld C, Schanz S, Kern JS, Hofmann S, Bouyeure AC, Picard-Dahan C, Prost-Squarcioni C, Caux F, Alexandre M, Ingen-Housz-Oro S, Bagot M, Tancrede-Bohin E, Bouaziz JD, Franck N, Vabres P, Labeille B, Richard MA, Delaporte E, Dupuy A, D'Incan M, Quereux G, Skowro F, Paul C, Livideanu CB, Beylot-Barry M, Doutre MS, Avenel-Audran M, Bedane C, Bernard P, Machet L, Maillard H, Jullien D, Debarbieux S, Sassolas B, Misery L, Abasq C, Dereure O, Lagoutte P, Ferranti V, Werth VP, Murrell DF, Hertl M, Benichou J, Joly P; French Study Group on Autoimmune Bullous Skin Diseases; Autoimmune Bullous Skin Disease Task Force of the European Academy of Dermatology and Venereology. Hébert V, et al. Among authors: abasq c. J Invest Dermatol. 2019 Jan;139(1):31-37. doi: 10.1016/j.jid.2018.04.042. Epub 2018 Oct 6. J Invest Dermatol. 2019. PMID: 30301637 Free article. Review.
Drug survival and postdrug survival of systemic treatments in a national French cohort of children with atopic dermatitis.
Chambrelan E, Barbarot S, Bekel L, Poizeau F, Mahé E, Puzenat E, Delaunay J, Mallet S, Bessis D, Maruani A, Miquel J, Raison-Peyron N, Abasq C, Phan A, Du Thanh A, Kupfer I, Bonniaud B, Bouzille G, Dupuy A, Droitcourt C; Groupe de Recherche sur l'Eczéma Atopique de la Société Française de Dermatologie (GREAT) and Société Française de Dermatologie Pédiatrique (SFDP). Chambrelan E, et al. Among authors: abasq c. Br J Dermatol. 2020 Aug;183(2):376-378. doi: 10.1111/bjd.18941. Epub 2020 Mar 20. Br J Dermatol. 2020. PMID: 32037515 Free article. No abstract available.
International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut-off values for defining mild, moderate and severe types of bullous pemphigoid.
Masmoudi W, Vaillant M, Vassileva S, Patsatsi A, Quereux G, Moltrasio C, Abasq C, Prost-Squarcioni C, Kottler D, Kiritsi D, Litrowski N, Plantin P, Friedrichsen L, Zebrowska A, Duvert-Lehembre S, Hofmann S, Ferranti V, Jouen F, Joly P, Hebert V; EADV Autoimmune Bullous Skin Disease Task Force. Masmoudi W, et al. Among authors: abasq c. Br J Dermatol. 2021 Jun;184(6):1106-1112. doi: 10.1111/bjd.19611. Epub 2020 Nov 29. Br J Dermatol. 2021. PMID: 33067805
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Series of 49 French Pediatric Cases.
Bedouelle E, Ben Said B, Tetart F, Milpied B, Welfringer-Morin A, Maruani A, Catteau B, Dezoteux F, Staumont-Sallé D, Mazereeuw-Hautier J, Abasq C, Chiaverini C, Delaunay J, Mallet S, Sterling B, Puzenat E, Raynal M, Collet E, Bernier C; Groupe FISARD de la Société Française de Dermatologie and the Groupe de Recherche de la Société Française de Dermatologie Pédiatrique. Bedouelle E, et al. Among authors: abasq c. J Allergy Clin Immunol Pract. 2022 Jan;10(1):267-274.e5. doi: 10.1016/j.jaip.2021.07.025. Epub 2021 Jul 29. J Allergy Clin Immunol Pract. 2022. PMID: 34332174
Reasons for discontinuation of dupilumab in adult atopic dermatitis in clinical practice.
Marniquet ME, Seneschal J, Darrigade AS, Staumont-Sallé D, Jachiet M, Nosbaum A, Tauber M, Abasq C, Ferrier Le Bouedec MC, Droitcourt C, Aubert H, Bernier C, Soria A, Raison-Peyron N, Tétart F, Aubin F, Viguier M, Valois A, Kupfer-Bessaguet I, Goronflot T, Barbarot S; Groupe de Recherche sur l’Eczéma Atopique (GREAT). Marniquet ME, et al. Among authors: abasq c. Br J Dermatol. 2022 Apr;186(4):733-735. doi: 10.1111/bjd.20883. Epub 2022 Jan 20. Br J Dermatol. 2022. PMID: 34748654 No abstract available.
Anti-BP180 IgG antibody ELISA values correlate with adverse pregnancy outcomes in pemphigoid gestationis.
Cordel N, Flament J, Jouen F, Seta V, Tancrède-Bohin E, Dahan CP, Konstantinou MP, Dereure O, Quéreux G, Prost C, Bedane C, Debarbieux S, Lacour JP, Dompmartin A, Wierzbicka-Hainaut E, Villada IB, Oro SIH, Vabres P, Richard MA, Delaporte E, Pham-Ledard A, Leccia MT, Litrowski N, Michel C, Lagrange B, D'Incan M, Abasq C, Duvert-Lehembre S, Dupuy A, Alcaraz I, Breton-Guitarian AL, Lombart F, Estève E, Machet L, Del Giudice P, Fenot M, Belmondo T, Morin F, Guérin O, Benichou J, Tressières B, Joly P; French study Group on autoimmune bullous skin diseases. Cordel N, et al. Among authors: abasq c. J Eur Acad Dermatol Venereol. 2023 Jun;37(6):1207-1214. doi: 10.1111/jdv.18973. Epub 2023 Mar 6. J Eur Acad Dermatol Venereol. 2023. PMID: 36802102
49 results